CSE:VEXT - Post Discussion
Post by
Betteryear2 on Apr 20, 2022 4:28pm
Vext Announces Strong Growth for 2021
Revenue of $37.2 Million up 48%, Adjusted EBITDA of $13.4 Million up 100%
- Q4-2021 revenue of $9.3 million, +45% vs. Q4-2020; Adjusted EBITDA of $3.4 million, +47% vs. prior year period. Cash flow from operations was $4.8 million.
- FY-2021 revenue of $37.2 million, + 48% vs. FY-2020; Adjusted EBITDA of $13.4 million, +100% vs. prior year period. Cash flow from operations was $11.7 million (87% of Adjusted EBITDA).
- Experienced senior financial and operations executive Daniel Engel, CPA to join the Company as CFO, effective May 2, 2022. Current CFO Vahan Ajamian will remain for a planned transition through May 31, 2022.
- The Company will hold a conference call and webcast on Wednesday, April 20, 2022, at 8am ET to review financial results.
VANCOUVER, BC, April 20, 2022 /CNW/ - Vext Science, Inc. ("VEXT" or the "Company") (OTCQX: VEXTF) (CSE: VEXT) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today reported its financial results for the period ended December 31, 2021. All currency references used in this news release are in U.S. currency unless otherwise noted.
https://www.newswire.ca/en/releases/archive/April2022/20/c0934.html
Be the first to comment on this post